These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17030732)

  • 1. Acute respiratory distress due to verteporfin infusion for photodynamic therapy.
    Fossarello M; Peiretti E
    Arch Ophthalmol; 2006 Oct; 124(10):1509-10. PubMed ID: 17030732
    [No Abstract]   [Full Text] [Related]  

  • 2. Choroidal infarction following photodynamic therapy with verteporfin.
    Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faÿsse M; Coscas G; Gross NE; Yannuzzi LA
    Arch Ophthalmol; 2005 Aug; 123(8):1149-53. PubMed ID: 16087856
    [No Abstract]   [Full Text] [Related]  

  • 3. Accidental pregnancy exposure to verteporfin: obstetrical and neonatal outcomes: a case report.
    Rodrigues M; Meira D; Batista S; Carrilho MM
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):236-7. PubMed ID: 19432621
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral punctal-canalicular stenosis following photodynamic therapy for choroidal neovascularization.
    Yim JF; Crofts KP
    Cutan Ocul Toxicol; 2011 Mar; 30(1):78-9. PubMed ID: 20950246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased and persisted subretinal haemorrhage after photodynamic therapy for choroidal neovascularization secondary to angioid streaks.
    Shyong MP; Chen SJ; Lee FL; Tsao YP; Hsu WM
    Eye (Lond); 2006 Dec; 20(12):1420-2. PubMed ID: 16645630
    [No Abstract]   [Full Text] [Related]  

  • 6. Back pain after photodynamic therapy with verteporfin.
    Pece A; Vadalà M; Manzi R; Calori G
    Am J Ophthalmol; 2006 Mar; 141(3):593-4. PubMed ID: 16490525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy associated with photodynamic therapy for treatment of idiopathic choroidal neovascularization.
    Sii F; Lee LR
    Clin Exp Ophthalmol; 2006 Mar; 34(2):184-6. PubMed ID: 16626441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potentially life-threatening adverse reaction to verteporfin.
    Noffke AS; Jampol LM; Weinberg DV; Muñana A
    Arch Ophthalmol; 2001 Jan; 119(1):143. PubMed ID: 11146745
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonarteritic anterior ischemic optic neuropathy after photodynamic therapy for choroidal neovascularization.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2004; 48(4):424-6. PubMed ID: 15295679
    [No Abstract]   [Full Text] [Related]  

  • 12. Verteporfin infusion-associated pain.
    Borodoker N; Spaide RF; Maranan L; Murray J; Freund KB; Slakter JS; Sorenson JA; Yannuzzi LA; Guyer DR; Fisher YL
    Am J Ophthalmol; 2002 Feb; 133(2):211-4. PubMed ID: 11812424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous diclofenac as prophylactic treatment for verteporfin-associated low back pain.
    Theelen T; Hoyng CB
    Eur J Ophthalmol; 2008; 18(5):805-8. PubMed ID: 18850562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome.
    Kang SW; Kang SJ; Kim HO; Nam ES; Lee JH; Koh HJ
    Am J Ophthalmol; 2002 Dec; 134(6):907-8. PubMed ID: 12470762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.
    Sawa M; Ohji M; Gomi F; Kusaka S; Tano Y; Bressler NM
    Arch Ophthalmol; 2002 Nov; 120(11):1588-90. PubMed ID: 12427082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.